[ad_1]
OSLO, Feb 22 (Reuters) – Aluminium producer Norsk Hydro
has bought a minority stake in U.S. carbon capture firm
Verdox for $20 million and plans to use its technology at
smelters as part of wider efforts to cut emissions, the
Norwegian company said on Tuesday.
Hydro announced plans last year to slash its carbon dioxide
(CO2) emissions by 30% this decade and reach net zero by 2050 at
the latest, in line with the 2015 Paris climate accords designed
to limit global warming.
“More and more customers are requesting metals produced with
a smaller carbon footprint,” said Eivind Kallevik, head of
Hydro’s aluminium production division.
“The ultimate goal here is to deliver zero emissions from
the production process itself,” he told Reuters.
Hydro said that by applying Verdox technology at existing
smelters it would both speed up its decarbonisation and ensure
the plants could stay in operation for the long term.
Hydro and Verdox, a spinoff from the Massachusetts Institute
of Technology (MIT), both declined to give the size of the
Norwegian company’s stake.
Verdox announced on Feb. 2 that it had secured funding of
$80 million as it seeks to move its technology from the
laboratory to industrial facilities.
It listed Breakthrough Energy Ventures, which was founded by
Bill Gates, as one of the investors but did not disclose at the
time that Hydro was also among its sources of funding.
Kallevik said Hydro had evaluated more than 50 carbon
capture technologies before settling on the U.S. firm.
A Verdox spokesperson confirmed its collaboration with Hydro
but declined to name any of its other industrial partners,
citing confidentiality agreements.
Hydro is engaged in metal recycling to cut emissions and is
also developing new aluminium production technology with the aim
of delivering zero emissions at any future smelters it builds.
(Reporting by Terje Solsvik; Editing by David Clarke)
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Jessica Wilson
- Subash Kafle
- Jessica Wilson


















